Navigating UK and EU Food Supplement Compliance: Formulation and Labelling Standards

Maintaining regulatory compliance across the United Kingdom and the European Union remains an operational priority for food supplement brand owners, formulators, and contract manufacturers. Managing divergence between the post-Brexit Great Britain (GB) framework and established EU directives requires systematic oversight of product classification, nutrition and health claim verification, and analytical quality assurance protocols. ## The Regulatory Boundary: Food Supplements versus Medicinal Products A critical technical assessment during formulation development is the statutory demarcation between a food supplement and a medicinal product. In both jurisdictions, food supplements are legally classified as foodstuffs intended to supplement the normal diet, delivering concentrated sources of nutrients or other substances with a nutritional or physiological effect. The sector is governed under Directive 2002/46/EC in the EU and transposed national equivalents in the UK, such as the Food Supplements (England) Regulations 2003 and devolved legislation in Scotland, Wales, and Northern Ireland. A primary compliance risk is the inadvertent marketing of an unlicensed medicinal product. Under the UK Human Medicines Regulations 2012 and EU Directive 2001/83/EC, a product is categorised as medicinal either by presentation (claiming to treat, prevent, or cure adverse human health conditions or disease) or by function (exerting a significant pharmacological, immunological, or metabolic action). Formulators must ensure active botanical compounds, vitamins, and minerals remain strictly within physiological thresholds, avoiding therapeutic potencies that trigger intervention from regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA) or EU national competent authorities. ## Health Claims Verification and Statutory Registers Commercial pack copy and marketing collateral must align with applicable nutrition and health claims frameworks. Following the conclusion of the Brexit transition period, Great Britain maintains an independent GB Nutrition and Health Claims (NHC) Register, administered by the Department of Health and Social Care (DHSC) in collaboration with the Food Standards Agency (FSA). Northern Ireland and EU member states remain subject to Regulation (EC) No 1924/2006, evaluated scientifically by the European Food Safety Authority (EFSA). Key compliance requirements include: - Restricting consumer-facing messaging strictly to authorised claims listed on the applicable statutory register. - Complying with specific conditions of use, including minimum qualifying thresholds of the active nutrient per quantified daily dose (typically a significant amount, defined as 15% of the Nutrient Reference Value for vitamins and minerals in solid food supplements). - Maintaining exact alignment with authorised claim wording without extrapolating into medicinal or therapeutic outcomes. - Managing botanical claims on the 'on-hold' list, where application remains governed by national transitional guidance and general food law requirements prohibiting misleading information. Non-compliance in labelling or promotional copy exposes brand owners to statutory enforcement, including formal improvement notices, mandatory product withdrawals, and sanctions from advertising authorities such as the UK Advertising Standards Authority (ASA). ## Analytical Quality Assurance and Due Diligence Beyond formulation thresholds and labelling copy, manufacturers and brand owners carry statutory duties under general food law (Regulation (EC) No 178/2002 and retained UK equivalents) to verify product safety and maintain complete traceability throughout the supply chain. Hazard Analysis Critical Control Point (HACCP) systems and Good Manufacturing Practice (GMP) standards form the foundational operational framework. Analytical testing regimes must routinely confirm that finished batches meet finished product specifications. This includes batch screening for heavy metals (lead, cadmium, mercury, and arsenic) against maximum statutory limits, microbiological screening, and monitoring for solvent and pesticide residues. Furthermore, real-time and accelerated stability testing programmes must validate that declared active levels meet label declarations throughout the stated shelf life, while ensuring any formulation overages do not exceed established upper safe levels.